Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases

Experimental Eye Research

Volumn 67, Issue 1, 1998, Pages 9-19

  Thakur, A ^a   Willcox, M D P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

B4; Contact lens; Cytokines; Keratitis; Leukotriene

Indexed keywords

CHEMOATTRACTANT; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LIPID; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; CORNEA ULCER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KERATITIS; LACRIMAL FLUID; LEUKOCYTE ACTIVATION; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SEROTONIN RELEASE; THROMBOCYTE RELEASE REACTION;

EID: 0032128069     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1998.0480     Document Type: Article

References (50)

1. Agace, W., Hedges, S., Andersson, U., Andersson, J., Ceska, M. and Svanborg, C. (1993). Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect. Immun. 61, 602-9.
2. Alekseev V. N., Ketlinskaia O. S., Gruzinova T. L. Cytokines in the tear fluid and their roles in the pathogenesis of ophthalmic herpes. Vestnik Rossiiskoi Akad. Med. Nauk. 1:1996;57-59.
3. Bates A. K., Morris R. J., Stapleton F., Minassian D. C., Dart J. K. G. 'Sterile' corneal infiltrates in contact lens wearers. Eye. 3:1989;803-810.
4. Bazan H. E. P., Birkle D. L., Beuerman R., Bazan N. G. Cryogenic lesions alters the metabolism of arachidonic acid in rabbit cornea layers. Invest. Ophthalmol. Vis. Sci. 26:1985;474-480.
5. Bazan H. E. P., Braquet P., Reddy S. T. K., Bazan N. G. Inhibition of alkali burn-induced lipoxygenation of arachidonic acid in the rabbit cornea in vivo by a platelet activating factor antagonist. J. Ocul. Pharmacol. 3:1987;357-365.
6. Bray M. A. Leukotrienes in inflammation. Agents Actions. 19:1986;87-99.
7. Conners M. S., Stlotz R. A., Webb S. C., Rosenberg J., Dunn M. W., Abraham N. G., Laniado-Schwartzman M. A closed eye contact lens model of corneal inflammation. Invest. Ophthalmol. Vis. Sci. 36:1995;828-840.
8. Cubitt C. L., Tang Q., Monteiro C. A., Lausch R. N., Oakes J. E. IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 34:1993;3199-3206.
9. Cubitt C. L., Lausch R. N., Oakes J. E. Differential regulation of GM-CSF gene expression in human corneal cells by proinflammatory cytokines. J. Immunol. 153:1994;232-240.
10. Cubitt C. L., Lausch R. N., Oakes J. E. Differences in IL-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 36:1995;330-336.
11. Dart J. K. G., Stapleton F., Minassian D. Contact lens and other risk factors in microbial keratitis. Lancet. 338:1991;650-653.
12. 4. J. Immunol. 140:1988;4315-4322.
13. Elner V. M., Strieter R. M., Pavilack M. A., Elner S. G., Pernick D. G., Danforth J. M., Kunkel S. L. Human corneal interleukin-8, IL-1 and TNF-induced gene expression and secretion. Am. J. Pathol. 139:1991;977-988.
14. Fukuda M., Mishima H., Otori T. Detection of IL-1β in the tear fluid of patients with Corneal disease with or without conjunctival involvement. Jpn J. Ophthalmol. 41:1997;63-66.
15. Grant T, Terry R., Holden B. A. Extended wear of hydrogen lenses: clinical problems and their management. Problems in Optometry. 1990;J. B. Lippincott. p. 599-622.
16. Guillon M., Guillon J. P., Bansal M., Maskell R., Rees P. Incidence of ulcers with conventional and disposable daily wear soft contact lenses. J. Brit. Contact Lens Assoc. 17:1994;69-76.
17. Gupta A., Monroy D., Ji Z., Yoshino K., Huang A., Pflugfelder S. C. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr. Eye Res. 15:1996;605-614.
18. Holden B. A., La Hood D., Grant T., Newton-Howes J., Baleriola-Lucas C., Willcox M. D. P., Sweeney D. F. Gram-negative bacteria can induce a contact lens related acute red eye (CLARE) response. CLAO J. 22:1996;47-52.
19. Holden B. A., Swarbrick H. A. Extended wear: physiological considerations. Stone J., Philips A. J. Contact lenses. 1989;1-15 Butterworth.
20. Humphrey D. M., McManus J., Statouchi K., Hanahan D. J. Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogs. Lab. Invest. 46:1982;422-426.
21. Kernacki, K. A. and Berk, R. S. (1995). Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 36, 16-23.
22. Limberg M. B., Birkle D. L., Bazan H. E. P., Bazan N. G. The effect of a new lipoxygenase inhibitor on the production of arachidonic acid metabolites during experimental herpes simplex keratitis. Curr. Eye Res. 7:1988;1131-1135.
23. 4. Am. Rev. Respir. Dis. 147:1993;A754.
24. 4. J. Immunol. 146:1991;1204-1211.
25. Mondino B. J. Inflammatory diseases of the peripheral cornea. Ophthalmol. 95:1988;463-472.
26. 4. Documenta Ophthalmologica. 85:1994;247-257.
27. O'Flaherty J. T., Wykle R. L., Lees C. J., Shewmake T., McCall C. E., Thomas M. J. Neutrophil degranulation action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-Oh-alkyll-2-Oacetyl-sn-glycero-3-phosphocholine. Comparison with other granulating agents. Am. J. Pathol. 105:1981;254-269.
28. Ohashi Y., Motokura M., Kinoshita Y., Mano T., Watanabe H., Kinoshita S., Manabe R., Oshiden K., Yanaihara C. Presence of epidermal growth factor in human tears. Invest. Ophthalmol. Vis. Sci. 30:1989;1879-1882.
29. Ramachandran L., Sharma S., Sankaridurg P. R., Vajdic C. M., Chuck J. A., Holden B. A., Sweeney D. F., Rao G. N. Examination of the conjunctival microbiota and 8 hr of eye closure. CLAO J. 21:1995;195-199.
30. Rot A. Some aspects of NAP-1 pathophysiology: lung damage caused by a blood-borne cytokine. Westwick J. et al. Chemotactic cytokines. 1991;127-135 Plenum Press.
31. Sack R. A., Tan K. O., Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 33:1992;626-640.
32. Sankaridurg P. R., Willcox M. D. P., Sharma S., Gopinathan U., Janakiraman D., Hickson S., Vuppala N., Sweeney D. F., Rao G. N., Holden B. A. Haemophilus influenzae. J. Clin. Microbiol. 34:1996;2426-2431.
33. 4. J. Immunol. 138:1987;3918-3921.
34. Smolin G., Okumoto M. Staphylococcal blepharitis. Arch. Ophthamol. 95:1977;812-816.
35. Snyder C. Infiltrative keratitis with contact lens wear - a review. J. Am. Optom. Assoc. 66:1995;160-177.
36. Stapleton F., Willcox M. D. P., Fleming C. M., Hickson S., Sweeney D. F., Holden B. A. Changes to the ocular biota with time in extended and daily wear disposable contact lens use. Infect. Immun. 21:1995;195-199.
37. Stein R. M., Clinch T. E., Cohen E. J., Genvert G. I., Arentsen J. J., Laibson P. R. Infected vs. sterile corneal infiltrates in contact lens wearers. Am. J. Ophthalmol. 105:1988;632-636.
38. Tervo T., Vesaluoma M., Bennett G. L., Schwall R., Helena M., Liange Q., Wilson S. E. Tear hepatocyte growth factor production increases markedly after excimer laser surface ablation. Exp. Eye Res. 64:1997;501-504.
39. Thakur, A. and Willcox, M. D. P. (1998). Chemotactic activity of tears and bacteria isolated during adverse responses. Exp. Eye Res. 66.
40. Torres P., deVos A. F., Gaag R. V. D., Kijlstra A. Expression of the interleukin 1 receptor antagonist in the normal human cornea. Ocular Immunol. Inflamm. 2:1994;217-222.
41. van Setten G., Schultz G. Transforming growth factor-alpha is a constant component of human tear fluid. Graefes Arch. Clin. Exp. Ophthalmol. 232:1994;523-526.
42. van Setten G. B., Schultz G. S., Macauley S. Growth factors in human tear fluid and in lacrimal glands. Adv. Exp. Med. Biol. 350:1994;315-319.
43. Vesaluoma M., Teppo A. M., Gronhagen-Riska C., Tervo T. Release of TGF-b1 and VEGF in tears following photorefractive keratectomy. Curr. Eye Res. 1:1997a;19-25.
44. Vesaluoma M., Teppo A. M., Gronhagen-Riska C., Tervo T. Platelet-derived growth factor-BB in tear fluid: a potential modulator of corneal wound healing following photorefractive keratectomy. Curr. Eye Res. 16:1997b;825-831.
45. Weisbart R. H., Kacena A., Schuh A., Golde D. W. GM-CSF induces human PMN IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature. 332:1988;647-648.
46. Weisbart R. H., Kwan L., Golde D. W., Gasson J. C. Human GM-CSF primes PMN for enhanced oxidative metabolism in response to the major physiologic chemoattractants. Blood. 69:1987;18-25.
47. Wakefield D., McCluskey P., Roche N., Rosio J. L. Aqueous humor cytokine profile in patients with chronic uveitis. Ocular Immunol. Inflamm. 3:1995;203-208.
48. Willcox M. D. P., Sweeney D. F., Sharma S., Gopinathan U., Sankridurg P. R., Ramachandran L., Holden B. A., Rao G. N. Culture negative peripheral ulcers are associated with bacterial contamination of contact lenses. ARVO abstract. Invest. Ophthalmol. Vis. Sci. 36:1995;S152.
49. Wirthmueller U., De Weck A. L., Dahinden C. A. PAF production in human PMN by sequential stimulation with GM-CSF and the chemotactic factors C5a or fMLP. J. Immunol. 142:1989;3213-3218.
50. Wykle R. L., O'Flaherty J. T., Thomas M. J. Platelet activating factor. Meth. Enzym. 163:1988;44-54.